Delivery Order SPE2DR25D3013-SPE2DR26F7B0E
Award Date 3/9/26
Potential Completion Date 3/10/26
Potential Value $5.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $29,144.65 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for ENBREL 50 mg/mL syringes with a completion date of March 3, 2026. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 and running through December 2026. This IDC provides comprehensive global pharmaceutical support across military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency issued a $5,082.52 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Enbrel 50 mg/ml syringes under the DLA Troop Support Medical IDC (SPE2DX). The parent IDC is valued at $999,999,999 and runs through December 2026, serving as a global pharmaceutical support vehicle for military healthcare programs. Place of performance is Conshohocken, PA. Ultimate completion date is March 5, 2026. Pricing is firm fixed price with no set-aside applied.
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Enbrel 50 mg/ml syringes, with a ceiling value of $61,661.39. The delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DX, a global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 3, 2026. The order is priced on a firm...
- The Defense Logistics Agency issued a $54,798.36 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Enbrel 50 mg/ml syringes with a completion date of February 13, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA 19428.
- <p>The Defense Logistics Agency issued a $8,474.57 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for ENBREL 25 MG/0.5 ML syringes.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 10, 2026. The order carries firm fixed pricing and was competitively awarded with no set-aside.</p>
- The Defense Logistics Agency issued a $41,726.92 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for ENBREL 50 MG/ML syringes with an ultimate completion date of February 25, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DX, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA....
- The Defense Logistics Agency issued a $27,219.85 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Enbrel Surclk 50mg 4s pharmaceutical supply. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026, enabling supply of a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of...
- <p>The Defense Logistics Agency issued a $36,630.53 delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for ENBREL 50 mg/ml syringes, with ultimate completion on February 24, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price and was not set aside.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for $10,165.06 to supply ENBREL 50 mg/ml syringes with an ultimate completion date of February 6, 2026. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Enbrel 50 mg/ml syringes with a ceiling value of $47,315.38, executed under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate completion date of March 5, 2026. No set-aside was used.</p>